Google快讯 - disease

	disease 实时更新 ⋅ 2026年2月6日
	网页
	What Counts as Successful NMOSD Treatment for Me? - Rare Disease Advisor Rare Disease Advisor However, by the time I received my official diagnosis, I was already on rituximab, among the most common treatments for the disease. Did this ... 标记为不相关
	Targeting tau in Alzheimer's Disease: rationale, approach and challenges - Springer Link Springer Link The physiological roles of Tau and Aβ: implications for alzheimer's disease pathology and therapeutics. Acta Neuropathol Springer Sci Bus Media ... 标记为不相关
	Treatment Strategies and Disease Activity During Pregnancy and Postpartum - ZORA ZORA - Universität Zürich ... disease-modifying therapies (cHET: anti-CD20 monoclonal antibodies (aCD20) and natalizumab [NTZ]) with those where other therapeutic regimens ... 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈